These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8095737)

  • 1. A theory of dopamine function and its role in cognitive deficits in schizophrenia.
    Cohen JD; Servan-Schreiber D
    Schizophr Bull; 1993; 19(1):85-104. PubMed ID: 8095737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenic deficits: neuroleptics and the prefrontal cortex.
    Jobe TH; Harrow M; Martin EM; Whitfield HJ; Sands JR
    Schizophr Bull; 1994; 20(3):413-6; discussion 417-21. PubMed ID: 7973463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia.
    Cohen JD; Servan-Schreiber D
    Psychol Rev; 1992 Jan; 99(1):45-77. PubMed ID: 1546118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation.
    Hoffman RE; Buchsbaum MS; Escobar MD; Makuch RW; Nuechterlein KH; Guich SM
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):169-75. PubMed ID: 1821231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.
    Cassens G; Inglis AK; Appelbaum PS; Gutheil TG
    Schizophr Bull; 1990; 16(3):477-99. PubMed ID: 1981108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges.
    Cohen JD; Braver TS; O'Reilly RC
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1515-27. PubMed ID: 8941963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function.
    Braver TS; Barch DM; Cohen JD
    Biol Psychiatry; 1999 Aug; 46(3):312-28. PubMed ID: 10435197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.
    van Kammen DP
    Psychol Med; 1991 Nov; 21(4):881-95. PubMed ID: 1685791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia.
    Lawrie SM; Ingle GT; Santosh CG; Rogers AC; Rimmington JE; Naidu KP; Best JJ; O'Carroll Re; Goodwin GM; Ebmeier KP
    Br J Psychiatry; 1995 Aug; 167(2):202-10. PubMed ID: 7582670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenic deficits in the processing of context. A test of a theoretical model.
    Servan-Schreiber D; Cohen JD; Steingard S
    Arch Gen Psychiatry; 1996 Dec; 53(12):1105-12. PubMed ID: 8956676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flat affect in schizophrenia: a test of neuropsychological models.
    Blanchard JJ; Kring AM; Neale JM
    Schizophr Bull; 1994; 20(2):311-25. PubMed ID: 8085134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological studies of sensory gating in schizophrenia.
    Freedman R; Adler LE; Gerhardt GA; Waldo M; Baker N; Rose GM; Drebing C; Nagamoto H; Bickford-Wimer P; Franks R
    Schizophr Bull; 1987; 13(4):669-78. PubMed ID: 2894074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need to integrate neuropsychological and experimental schizophrenia research.
    Serper MR; Harvey PD
    Schizophr Bull; 1994; 20(1):1-11; discussion 13-21. PubMed ID: 8197408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neural network model of cortical information processing in schizophrenia. I: Interaction between biological and social factors in symptom formation.
    Chen EY
    Can J Psychiatry; 1994 Oct; 39(8):362-7. PubMed ID: 7834591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention and higher cortical functions in schizophrenia.
    Kenny JT; Meltzer HY
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):269-75. PubMed ID: 1821243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairment in schizophrenia and how it affects treatment options.
    Bilder RM
    Can J Psychiatry; 1997 Apr; 42(3):255-64. PubMed ID: 9114941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of apomorphine on regional cerebral blood flow in schizophrenia.
    Daniel DG; Berman KF; Weinberger DR
    J Neuropsychiatry Clin Neurosci; 1989; 1(4):377-84. PubMed ID: 2521086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive subtypes of chronic schizophrenia.
    Heinrichs RW; Awad AG
    Schizophr Res; 1993 Mar; 9(1):49-58. PubMed ID: 8096391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel distributed processing and the emergence of schizophrenic symptoms.
    Hoffman RE; McGlashan TH
    Schizophr Bull; 1993; 19(1):119-40. PubMed ID: 8451607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.